CA
REGN icon

Cache Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Cache Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Hold
3,548
– – 0.19% 52
2026
Q1 		$2.74M Hold
3,548
– – 0.32% 24
2025
Q4 		$2.74M Sell
3,548
-2,752
-44% -$1.87M 0.34% 22
2025
Q3 		$3.54M Sell
6,300
-2,316
-27% -$1.31M 0.62% 21
2025
Q2 		$4.52M Hold
8,616
– – 1.22% 18
2025
Q1 		$5.46M Buy
8,616
+4,756
+123% +$3.27M 2.1% 11
2024
Q4 		$2.75M Buy
+3,860
New +$3.24M 1.15% 19

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Cache Advisors's REGN Position: Q2 2026 in Review

Cache Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 3,548 shares worth $2.21M. The position accounts for 0.19% of the portfolio, ranked #52.

Cache Advisors first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.46M in Q1 2025. 262 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Cache Advisors held 3,548 shares of Regeneron Pharmaceuticals worth $2.21M as of Q2 2026.
  • Cache Advisors left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.19% of Cache Advisors's portfolio in Q2 2026, its #52 holding.
  • Cache Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Cache Advisors's Regeneron Pharmaceuticals position peaked at $5.46M in Q1 2025.
  • 262 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Cache Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.